{"id":"https://openalex.org/W7202378071","doi":"https://doi.org/10.1155/dth/1342428","title":"Redrawing the Map in Prurigo Nodularis: From Conventional Approaches to Targeted Biologics","display_name":"Redrawing the Map in Prurigo Nodularis: From Conventional Approaches to Targeted Biologics","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7202378071","doi":"https://doi.org/10.1155/dth/1342428"},"language":"en","primary_location":{"id":"doi:10.1155/dth/1342428","doi":"https://doi.org/10.1155/dth/1342428","is_oa":true,"landing_page_url":"https://doi.org/10.1155/dth/1342428","pdf_url":null,"source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1155/dth/1342428","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005496876","display_name":"G\u00f6knur Kalkan","orcid":"https://orcid.org/0000-0002-2358-7938","observed_orcids":["https://orcid.org/0000-0002-2358-7938"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"G\u00f6knur Kalkan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2358-7938","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5005496876"],"corresponding_institution_ids":[],"apc_list":{"value":2700,"currency":"USD","value_usd":2700},"apc_paid":{"value":2700,"currency":"USD","value_usd":2700},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.62688729,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2026","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13597","display_name":"Medicine and Dermatology Studies History","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prurigo-nodularis","display_name":"prurigo nodularis","score":1.0},{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":0.8029999732971191},{"id":"https://openalex.org/keywords/nemolizumab","display_name":"nemolizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/il-4-il-13-pathway","display_name":"IL-4/IL-13 pathway","score":0.9110000133514404},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mast-cell-targeted-therapy","display_name":"mast cell-targeted therapy","score":0.9580000042915344},{"id":"https://openalex.org/keywords/disease-endotypes","display_name":"disease endotypes","score":0.7490000128746033},{"id":"https://openalex.org/keywords/treatment-algorithm","display_name":"treatment algorithm","score":0.6209999918937683},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.7210000157356262},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.7149999737739563},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.951200008392334},{"id":"https://openalex.org/C2776266956","wikidata":"https://www.wikidata.org/wiki/Q3924802","display_name":"Prurigo nodularis","level":2,"score":0.9075000286102295},{"id":"https://openalex.org/C2779824493","wikidata":"https://www.wikidata.org/wiki/Q5315925","display_name":"Dupilumab","level":3,"score":0.8830000162124634},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.6273000240325928},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5101000070571899},{"id":"https://openalex.org/C2781431837","wikidata":"https://www.wikidata.org/wiki/Q3408668","display_name":"Prurigo","level":2,"score":0.42329999804496765},{"id":"https://openalex.org/C188313352","wikidata":"https://www.wikidata.org/wiki/Q119697","display_name":"Off-label use","level":2,"score":0.4221000075340271},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4169999957084656},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41449999809265137},{"id":"https://openalex.org/C2780113039","wikidata":"https://www.wikidata.org/wiki/Q419820","display_name":"Azelastine","level":2,"score":0.3659000098705292},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.3619999885559082},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.357699990272522},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.33559998869895935},{"id":"https://openalex.org/C2780938799","wikidata":"https://www.wikidata.org/wiki/Q2853347","display_name":"Antipruritic","level":2,"score":0.33149999380111694},{"id":"https://openalex.org/C2992053201","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Clinical efficacy","level":2,"score":0.32710000872612},{"id":"https://openalex.org/C19648533","wikidata":"https://www.wikidata.org/wiki/Q691640","display_name":"Evidence-based medicine","level":3,"score":0.2791999876499176},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.2750000059604645},{"id":"https://openalex.org/C2779903281","wikidata":"https://www.wikidata.org/wiki/Q6888026","display_name":"Modalities","level":2,"score":0.27379998564720154},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.272599995136261},{"id":"https://openalex.org/C2993247534","wikidata":"https://www.wikidata.org/wiki/Q621261","display_name":"Pain relief","level":2,"score":0.26570001244544983},{"id":"https://openalex.org/C2777107010","wikidata":"https://www.wikidata.org/wiki/Q2798704","display_name":"Neuropathic pain","level":2,"score":0.26489999890327454},{"id":"https://openalex.org/C3019692148","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Therapeutic modalities","level":2,"score":0.262800008058548},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.25619998574256897}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1155/dth/1342428","doi":"https://doi.org/10.1155/dth/1342428","is_oa":true,"landing_page_url":"https://doi.org/10.1155/dth/1342428","pdf_url":null,"source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:5483e0a7869f4a6f905d78cdf6b3f8ba","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5483e0a7869f4a6f905d78cdf6b3f8ba","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Dermatologic Therapy, Vol 2026, Iss 1, Pp n/a-n/a (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1155/dth/1342428","doi":"https://doi.org/10.1155/dth/1342428","is_oa":true,"landing_page_url":"https://doi.org/10.1155/dth/1342428","pdf_url":null,"source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W2416808022","https://openalex.org/W2560241836","https://openalex.org/W2891865919","https://openalex.org/W2910893259","https://openalex.org/W2954975475","https://openalex.org/W3027784176","https://openalex.org/W3211666669","https://openalex.org/W4223979527","https://openalex.org/W4292572546","https://openalex.org/W4306385445","https://openalex.org/W4386814999","https://openalex.org/W4388944875","https://openalex.org/W4390976654","https://openalex.org/W4391642525","https://openalex.org/W4391746574","https://openalex.org/W4396806506","https://openalex.org/W4399363872","https://openalex.org/W4409033471","https://openalex.org/W4410417940","https://openalex.org/W4415321652"],"related_works":["https://openalex.org/W7203501846","https://openalex.org/W4410417940","https://openalex.org/W4402770539","https://openalex.org/W4409033471","https://openalex.org/W3185895263","https://openalex.org/W4415435565","https://openalex.org/W4408515242","https://openalex.org/W4225015640","https://openalex.org/W3164187385","https://openalex.org/W4414084184"],"abstract_inverted_index":{"Background":[0],"Prurigo":[1],"nodularis":[2],"(PN)":[3],"is":[4,160],"a":[5,162],"chronic,":[6],"neuroimmune\u2010mediated":[7],"dermatosis":[8],"characterized":[9],"by":[10,150],"intense":[11],"pruritus":[12,146],"and":[13,50,60,75,85,95,114,131,147,177,180,196],"nodular":[14],"lesions":[15],"that":[16,137],"severely":[17],"impair":[18],"patient":[19],"quality":[20],"of":[21,25,63,158],"life.":[22],"The":[23,156],"limitations":[24],"conventional":[26,96],"therapies":[27,97],"in":[28,144],"providing":[29],"more":[30,186],"than":[31],"symptomatic":[32],"relief":[33],"have":[34],"necessitated":[35],"novel":[36],"approaches":[37,173],"targeting":[38],"the":[39,51,58,109,115],"disease\u2019s":[40],"heterogeneous":[41],"pathogenesis.":[42],"Objective":[43],"This":[44],"review":[45,121],"evaluates":[46],"current":[47],"treatment":[48],"algorithms":[49],"potential":[52,193],"future":[53,175],"clinical":[54,83,198],"frameworks":[55],"tailored":[56],"to":[57,89,104,169],"immunological":[59],"neuropathic":[61],"endotypes":[62,185],"PN.":[64],"Methods":[65],"A":[66],"comprehensive":[67],"literature":[68],"search":[69],"was":[70],"conducted":[71],"across":[72],"PubMed/MEDLINE,":[73],"Scopus,":[74],"Google":[76],"Scholar":[77],"databases":[78],"for":[79,98,191],"English\u2010language":[80],"peer\u2010reviewed":[81],"articles,":[82],"trials,":[84],"guidelines":[86],"published":[87],"up":[88],"December":[90],"2025,":[91],"focusing":[92],"on":[93],"targeted":[94,139],"prurigo":[99],"nodularis.":[100],"Results":[101],"In":[102],"addition":[103],"approved":[105],"biologics":[106],"such":[107],"as":[108],"IL\u20104/IL\u201013":[110],"pathway":[111],"inhibitor":[112],"dupilumab":[113],"IL\u201031":[116],"receptor":[117],"antagonist":[118],"nemolizumab,":[119],"this":[120],"discusses":[122],"emerging":[123,167],"options,":[124],"including":[125],"JAK":[126],"inhibitors,":[127],"mast":[128],"cell\u2013targeted":[129],"therapies,":[130],"opioid":[132],"modulators.":[133],"Current":[134],"evidence":[135],"suggests":[136],"these":[138,184],"agents":[140],"offer":[141],"significant":[142],"improvements":[143],"both":[145],"lesion":[148],"resolution":[149],"addressing":[151],"specific":[152],"molecular":[153],"drivers.":[154],"Conclusion":[155],"management":[157],"PN":[159],"entering":[161],"transitional":[163],"phase,":[164],"with":[165],"an":[166],"goal":[168],"evolve":[170],"from":[171],"uniform":[172],"toward":[174],"biomarker\u2010":[176],"phenotype\u2010based,":[178],"disease\u2010modifying,":[179],"personalized":[181],"strategies.":[182],"Defining":[183],"precisely":[187],"will":[188],"be":[189],"essential":[190],"optimizing":[192],"therapeutic":[194],"individualization":[195],"long\u2010term":[197],"success.":[199]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2026-08-14T00:00:00"}